Human Capital Lessons: A Year in Review
ACG CEO Tom Bohn chats with Insperity CEO Paul Sarvadi about the human capital lessons we can take from 2021 into 2022 and beyond.
GrowthTV
Navigating Physician Practice M&A
Three experts from DHG Healthcare give an overview of the ever-complex healthcare field, and what owners look for in a deal.
Evolving Considerations Around Technology M&A
M&A attorney Karen Hermann shares how she sees tech deals evolving and best practices for prospective sellers to attract the ideal buyer.
Middle-Market Solutions for Shipping
Jordan Zapotechne of Enterprise Purchasing Group and Sean Doherty of Maersk discuss the global shipping market and options for midsize companies.
Shipping Insights and Advice For the Middle Market
Jordan Zapotechne with the Enterprise Purchasing Group offers three ways operators can mitigate the impact of price hikes and uncertainty in shipping.
Assessing Value & Risk in Healthcare Transactions
In this episode, Beth Mullins and Wayne Little, Principal and Partner at DHG Healthcare respectively, describe important considerations in the ever more complex world of healthcare transactions.
Panel Discussion: Betting on Residential and Commercial Services
Moderator Nevin Raj, COO and co-founder of Grata, is joined by Brian Rassel, a partner at Huron Capital, and Brent Kulman, head of business development at Five Points Capital to discuss activity in the residential and commercial services sector, as well as which opportunities remain moving forward.
Beyond COVID: Business Incentives to Drive Growth
As business leaders’ mindsets pivot from a state of survival to recovery and growth, hear about the incentives landscape that lays ahead to help businesses put COVID in the rearview.
The Maturity Curve for Tech-Driven Deal Sourcing
Evidence shows that firms that adopt technology solutions see the payoff in IRR and deal volume. In this episode, hear about the trends and best practices of supercharging deal sourcing with technology.
M&A Considerations Related to COVID Relief Programs
COVID relief programs injected billions of dollars into American businesses. Here's how dealmakers can manage the implications of these programs.